HELP
Cybin Inc. Common Stock
NYSE MKT: HELP · HEALTHCARE · BIOTECHNOLOGY
$5.31
+8.15% today
Updated 2026-04-30
Market cap
$269.43M
P/E ratio
—
P/S ratio
16,436.36x
EPS (TTM)
$-4.30
Dividend yield
—
52W range
$4 – $10
Volume
1.3M
Cybin Inc. Common Stock (HELP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $864000.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | -100.0% | — | — | — |
| Cost of revenue | — | — | — | — | $1.18M | $168000.00 | $251000.00 | $424000.00 | $472270.00 |
| Gross profit | — | — | — | — | $-311000.00 | $-168000.00 | $-251000.00 | $-424000.00 | $-472270.00 |
| Gross margin | — | — | — | — | -36.0% | — | — | — | — |
| R&D | — | — | — | $321600.00 | $3.30M | $17.59M | $25.49M | $32.36M | $54.91M |
| SG&A | — | — | — | $1.36M | $25.87M | $44.79M | $25.15M | $42.68M | $84.95M |
| Operating income | $-127000.00 | $-189946.00 | $-80520.00 | $-1.95M | $-31.04M | $-63.84M | $-51.52M | $-78.84M | $-143.15M |
| Operating margin | — | — | — | — | -3592.0% | — | — | — | — |
| EBITDA | $-127000.00 | $-220806.00 | $-101009.00 | $9600.00 | $-30.99M | $-63.67M | $-51.27M | $-78.41M | $-142.67M |
| EBITDA margin | — | — | — | — | -3586.3% | — | — | — | — |
| EBIT | — | — | $-262150.00 | $-1.94M | $-31.04M | $-63.84M | $-51.52M | $-78.84M | $-143.15M |
| Interest expense | — | — | — | — | $10000.00 | $241000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-127000.00 | $-220806.00 | $-101000.00 | $-1.94M | $-32.22M | $-67.63M | $-47.49M | $-78.08M | $-113.14M |
| Net income growth (YoY) | — | -73.9% | +54.3% | -1824.8% | -1557.4% | -109.9% | +29.8% | -64.4% | -44.9% |
| Profit margin | — | — | — | — | -3729.2% | — | — | — | — |